WO1997040812A1 - Enhanced zinc containing oral composition - Google Patents
Enhanced zinc containing oral composition Download PDFInfo
- Publication number
- WO1997040812A1 WO1997040812A1 PCT/US1997/006758 US9706758W WO9740812A1 WO 1997040812 A1 WO1997040812 A1 WO 1997040812A1 US 9706758 W US9706758 W US 9706758W WO 9740812 A1 WO9740812 A1 WO 9740812A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- zinc
- oral composition
- composition
- improved oral
- essential oils
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 122
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 title claims description 8
- 239000011701 zinc Substances 0.000 title claims description 8
- 229910052725 zinc Inorganic materials 0.000 title claims description 8
- 239000000551 dentifrice Substances 0.000 claims abstract description 52
- 239000000341 volatile oil Substances 0.000 claims abstract description 51
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims abstract description 44
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims abstract description 41
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims abstract description 32
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000011592 zinc chloride Substances 0.000 claims abstract description 23
- 235000005074 zinc chloride Nutrition 0.000 claims abstract description 21
- 239000005844 Thymol Substances 0.000 claims abstract description 19
- 229960000790 thymol Drugs 0.000 claims abstract description 19
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 17
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229940041616 menthol Drugs 0.000 claims abstract description 17
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229960005233 cineole Drugs 0.000 claims abstract description 16
- 229960001047 methyl salicylate Drugs 0.000 claims abstract description 16
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 claims abstract description 15
- 230000003385 bacteriostatic effect Effects 0.000 claims abstract description 15
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 12
- 230000002272 anti-calculus Effects 0.000 claims abstract description 10
- 239000004599 antimicrobial Substances 0.000 claims abstract description 9
- 239000000796 flavoring agent Substances 0.000 claims description 14
- 150000003751 zinc Chemical class 0.000 claims description 12
- 235000019634 flavors Nutrition 0.000 claims description 11
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- 235000003599 food sweetener Nutrition 0.000 claims description 10
- 239000003765 sweetening agent Substances 0.000 claims description 10
- 239000004094 surface-active agent Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000003086 colorant Substances 0.000 claims description 7
- 239000003906 humectant Substances 0.000 claims description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000002324 mouth wash Substances 0.000 claims description 6
- 239000011787 zinc oxide Substances 0.000 claims description 5
- 229940051866 mouthwash Drugs 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 claims description 4
- UAYWVJHJZHQCIE-UHFFFAOYSA-L zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 claims description 4
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 claims description 4
- 239000000872 buffer Substances 0.000 claims description 3
- 239000004408 titanium dioxide Substances 0.000 claims description 3
- 239000002535 acidifier Substances 0.000 claims description 2
- 229940095602 acidifiers Drugs 0.000 claims description 2
- 150000001734 carboxylic acid salts Chemical class 0.000 claims description 2
- 229940102001 zinc bromide Drugs 0.000 claims description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 2
- 239000011686 zinc sulphate Substances 0.000 claims description 2
- 235000009529 zinc sulphate Nutrition 0.000 claims description 2
- 239000000606 toothpaste Substances 0.000 abstract description 4
- 229940034610 toothpaste Drugs 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 239000007937 lozenge Substances 0.000 abstract description 2
- 239000004848 polyfunctional curative Substances 0.000 abstract description 2
- 238000003556 assay Methods 0.000 description 11
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 9
- 230000002421 anti-septic effect Effects 0.000 description 8
- 239000000499 gel Substances 0.000 description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 5
- 229910052731 fluorine Inorganic materials 0.000 description 5
- 239000011737 fluorine Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 239000005711 Benzoic acid Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 235000010233 benzoic acid Nutrition 0.000 description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000003082 abrasive agent Substances 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 235000012206 bottled water Nutrition 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- -1 gums Substances 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 3
- 235000010234 sodium benzoate Nutrition 0.000 description 3
- 239000004299 sodium benzoate Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 3
- 229940044613 1-propanol Drugs 0.000 description 2
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 2
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 235000013736 caramel Nutrition 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- JOZKFWLRHCDGJA-UHFFFAOYSA-N citronellol acetate Chemical compound CC(=O)OCCC(C)CCC=C(C)C JOZKFWLRHCDGJA-UHFFFAOYSA-N 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- 150000004673 fluoride salts Chemical class 0.000 description 2
- 229940091249 fluoride supplement Drugs 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 230000002070 germicidal effect Effects 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920001992 poloxamer 407 Polymers 0.000 description 2
- 229940044476 poloxamer 407 Drugs 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 239000001074 1-methoxy-4-[(E)-prop-1-enyl]benzene Substances 0.000 description 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- KFZXVMNBUMVKLN-UHFFFAOYSA-N 4-chloro-5-methyl-2-propan-2-ylphenol Chemical compound CC(C)C1=CC(Cl)=C(C)C=C1O KFZXVMNBUMVKLN-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- JOZKFWLRHCDGJA-LLVKDONJSA-N Citronellyl acetate Natural products CC(=O)OCC[C@H](C)CCC=C(C)C JOZKFWLRHCDGJA-LLVKDONJSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 239000005696 Diammonium phosphate Substances 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- BJIOGJUNALELMI-ONEGZZNKSA-N Isoeugenol Natural products COC1=CC(\C=C\C)=CC=C1O BJIOGJUNALELMI-ONEGZZNKSA-N 0.000 description 1
- 244000147568 Laurus nobilis Species 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 230000010757 Reduction Activity Effects 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 206010044029 Tooth deposit Diseases 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000006294 amino alkylene group Chemical group 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003610 anti-gingivitis Effects 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 239000007961 artificial flavoring substance Substances 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940119201 cedar leaf oil Drugs 0.000 description 1
- 229940031956 chlorothymol Drugs 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- BJIOGJUNALELMI-ARJAWSKDSA-N cis-isoeugenol Chemical compound COC1=CC(\C=C/C)=CC=C1O BJIOGJUNALELMI-ARJAWSKDSA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000003975 dentin desensitizing agent Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229910000388 diammonium phosphate Inorganic materials 0.000 description 1
- 235000019838 diammonium phosphate Nutrition 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 description 1
- 229940079886 disodium lauryl sulfosuccinate Drugs 0.000 description 1
- KHIQYZGEUSTKSB-UHFFFAOYSA-L disodium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O.CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O KHIQYZGEUSTKSB-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229910001385 heavy metal Chemical class 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 229910001506 inorganic fluoride Inorganic materials 0.000 description 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229940076522 listerine Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229940116837 methyleugenol Drugs 0.000 description 1
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000014569 mints Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 231100001160 nonlethal Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 229960004029 silicic acid Drugs 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- 229940048109 sodium methyl cocoyl taurate Drugs 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000001789 thuja occidentalis l. leaf oil Substances 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- BJIOGJUNALELMI-UHFFFAOYSA-N trans-isoeugenol Natural products COC1=CC(C=CC)=CC=C1O BJIOGJUNALELMI-UHFFFAOYSA-N 0.000 description 1
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
Definitions
- This invention relates to an improved anticalculus and antimicrobial effective oral composition
- a source of zinc ion in combination with essential oils such as thymol, eucalyptol, menthol, and methyl salicylate.
- Oral malodor reduction is also improved with the oral composition of this invention.
- the oral composition of this invention is in the form of a dentifrice, mouthwash and the like.
- Zinc ions in oral compositions are typically provided as water-soluble zinc salts or suspensions of zinc oxide particles. Oral compositions with zinc ions have enhanced bacteriostatic activity. They also have enhanced anticalculus activity.
- Essential oils are known to be germicidal. When used in oral compositions they reduce plaque, gingivitis, and oral malodor. Essential oils are aromatic compounds that are either derived from plant sources or are synthesized. Thymol is an essential oil that is well-known and widely used as an antimicrobial in oral compositions. Other essential oils include menthol, methyl salicylate, eucalyptol, anethol and eugenol. For example LISTERINE® antiseptic mouthwash has been marketed for over 100 years, and contains thymol, menthol, eucalyptol, and methyl salicylate More recently, essential oils have been included in formulations of dentifrice
- U S Patent No 4,022,880 to Vinson et al teaches a composition for inhibiting dental plaque and calculus comprising zinc ions and a non-toxic, organoleptically acceptable antibacterial agent
- U S Patent No 4,550,018 to Ambike et al teaches an oral composition with zinc chloride and essential oil However, the essential oil is in a flavor amount, not an antibacterial amount
- U S Patent No 4,568,540 to Asano et al teaches an oral hygiene composition containing an effective concentration of a pharmaceutically acceptable fluoride salt, a pharmaceutically acceptable zinc salt, a specific buffering agent, a suitable vehicle and having a pH of from about 3 5 to 6 0.
- U S Patent Nos 4,749,561 and 4,749,562 to Lane et al teaches a dentifrice including a substantially water-insoluble non-cationic antimicrobial agent or a zinc salt or a mixture thereof when the dentifrice comprises at least 0 2% by weight of a lamellar liquid crystal surfactant phase
- Figure 1 is a graph ofthe bacteriostatic efficacy of zinc ion dentrifrice compositions made with and without essential oils
- the oral composition of this invention comprises an anticalculus and bacteriostatic effective amount of zinc ion, an antimicrobial effective amount of one or more essential oils, and an orally acceptable vehicle or base
- the oral composition of this invention is preferably a dentifrice, such as toothpaste and gel Other compositions may include mouthwashes, mouthrinses, tooth powders, tooth hardeners, antitartar compositions, anticalculus compositions, gums, tablets, lozenges, troches and the like.
- the base or the medium for the active components ofthe composition of this invention will be any which is conventionally employed and known to those skilled in the art
- the zinc ion in the composition of this invention may be provided by a number of zinc-containing compounds
- the preferred source of zinc ion is one or more water- soluble zinc salts or zinc oxide.
- Suitable zinc salts include but are not limited to zinc sulphate, zinc chloride, zinc bromide, zinc iodide, zinc nitrate, and carboxylic acid salts of zinc
- the preferred zmc salt is zinc chloride
- the dentifrice composition of this invention is formulated to provide at least about 50 ppm of zinc ion, more preferably at least about 1500 ppm of zinc ion.
- the water-soluble zinc salt or salts are present in the composition of this invention in an amount of up to about 5% by weight ofthe composition (hereinafter "w/w"), preferably about 0 25 to about 3% w/w, and most preferably about 0 5 to about 2% w/w
- w/w the composition
- 0 01% zinc chloride by weight provides about 50 ppm zinc ion
- 0 2% zinc chloride by weight provides about 1000 ppm zinc ion
- 0 3% zinc chloride provides about 1500 ppm zinc ion.
- the preferred amount of zinc chloride in the dentifrice composition of this invention is, therefore, about 0 01% w/w; the more preferred amount of zinc chloride is about 0 2% w/w; and the most preferred amount is about 0.5% w/w
- Zinc ions can also be provided by suspensions of zinc oxide particles
- the zinc oxide is present in the composition in an amount sufficient to provide at least about 50 ppm zinc ion, preferably at least about 1500 ppm zinc ion
- Essential oils are volatile aromatic oils that may be synthetic or may be derived from plants by distillation, expression or extraction, and that usually carry the odor or flavor ofthe plant from which they are obtained Essential oils are widely used in oral care products Some essential oils show long-lasting germicidal effectiveness against the most common pathogens in the mouth These pathogens are frequently associated with oral malodor, plaque, and gingivitis
- the essential oils in the composition of this invention include but are not limited to thymol, methyl salicylate, menthol, eucalyptol, camphor, anethole, carvone, eugenol, isoeugenol, liminene, osimen, n-decyl alcohol, citronel, alpha-salpineol, methyl acetate, chlorothymol, citronellyl acetate, methyl eugenol, cineol, ethyl linalaol, safrola vinillin, spearmint oil,
- a dentifrice composition of this invention it is desirable that there be at least about 0 075% by weight of each of such four essential oils, preferably at least about 0 125% by weight, and most preferably at least about 0.2% by weight of each essential oil.
- Thymol also known by the chemical formula 5-methyl 2-( 1 -methylethyl) phenol, may be in the dentifrice composition of this invention in an amount of from about 0 01% w/w to about 1 0% w/w, preferably in an amount of from about 0 1% w/w to about 0 7% w/w, and most preferably in an amount of from about 0 2% w/w to about 0 6% w/w Menthol may be in the dentifrice composition ofthe present invention in an amount of from about 0 01% w/w to about 1 0% w/w, preferably in an amount of from about 0 10% w/w to about 0 7% w/w, and most preferably in an amount of from
- Eucalyptol may be in the dentifrice composition ofthe present invention in an amount of from about 0 01% w/w to about 1 0% w/w, preferably in an amount of from
- Methyl salicylate may be in the dentifrice composition ofthe present invention in an amount of from about 0 01% w/w to about 1.0% w/w, preferably in an amount of from about 0 04% w/w to about 0 8% w/w, and most preferably in an amount of from about
- the dentifrice composition ofthe invention may contain the following essential oils in percentages by weight (a) thymol from about 0 01% w/w to about 1 0% w/w, (b) menthol from about 0 01% w/w to about 1 0% w/w, (c) eucalyptol from about 0 01% w/w to about 1 0% w/w, and (d) methyl salicylate from about 0 01% w/w to about 1 0% w/w
- the dentifrice composition may contain the following essential oils in percentages by weight, (a) thymol from about 0 1% w/w to about 0 7% w/w, (b) menthol from about 0 1% w/w to about 0.7% w/w, (c) eucalyptol from about 0 05% w/w to about 0 5% w/w, and (d) methyl salicylate from about 0 04% w/w to about 0 8% w/w
- the dentifrice composition may contain the following essential oils in percentages by weight (a) thymol from about 0 2% w/w to about 0 6% w/w, (b) menthol from about 0.2% w/w to about 0.6% w/w; (c) eucalyptol from about 0.07% w/w to about 1.0% w/w; and (d) methyl salicylate from about 0.2% w/w to about 0.7% w/w.
- the total concentration by weight ofthe one or more essential oils is from about 0.1% w/w to about 4.0% w/w ofthe dentifrice composition. In the preferred embodiment the total concentration by weight ofthe one or more essential oils is from about 0.5% w/w to about 3.0% w/w. In the most preferred embodiment the total concentration by weight ofthe one or more essential oils from about 0.8% w/w to about 2.5% w/w.
- the dentifrice composition of this invention also comprises a liquid vehicle containing about 3-60% by weight of water, typically mixed with at least one humectant and a number of other ingredients.
- the liquid phase comprises about 20-90% by weight ofthe dentifrice and is generally about 25-80% liquid.
- Suitable humectants in the dentifrice include sorbitol, glycerin, propylene glycol, polyethylene glycol, sorbitan, fructose, mixtures thereof and the like. Humectants, when employed, may be present in amounts of from about 10% to about 50%, by weight ofthe dentifrice composition.
- the dentifrice also contains a gelling or binding agent as a solid vehicle agent.
- Gelling or binding agents which may be present include alkali metal carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, xanthan, thickening silicas, Irish moss, iota-carrageenan, gum tragacanth, polyethylene glycol, polyvinyl pyrrolidone, starch and mixtures thereof.
- any suitable surface active or detergent material may also be included in the dentifrice compositions.
- These surfactants may be non-ionic, amphoteric, cationic, or anionic.
- the most preferred surfactants are anionic.
- These anionic surfactants include but are not limited to sodium lauryl sulfate, sodium lauroyl sarcosinate, and sodium methyl cocoyl taurate, and disodium lauryl sulfosuccinate.
- the surfactant is the anionic surfactant sodium lauryl sulfate.
- Suitable nonionic surfactants in the present invention include poly(oxethylene)- poly(oxypropylene) block copolymers, also known commercially as poloxamers. Poloxamer surfactants in the present invention should have a Hydrophilic-Lipophilic Balance (HLB) of between about 10 and about 30, and preferably between about 10 and about 25.
- HLB Hydrophilic-Lipophilic Balance
- Amphoteric surfactants have the capacity to behave as either an acid or a base and include quatemized imidazole derivatives useful in the present invention.
- Preferred amphoteric agents include long chain (alkyl) amino-alkylene aklylated amine derivatives, also known as "Miranol", i.e., Miranol C 2 M, or N-alkyl betaine surfactants.
- Cationic surfactants are surfactants which carry a positive charge.
- Cationic surfactants especially useful in the present invention include antimicrobial quaternary ammonium salts.
- Fluorine-releasing compounds may be used in the dentifrice composition of this invention and may be fully or slightly water soluble.. These are chacterized by their ability to release fluoride ions or fluoride-containing ions in water and by their lack of reaction with other components in the composition..
- Typical fluorine-releasing compounds are inorganic fluoride salts such as water-soluble alkali metal, alkaline earth metal, and heavy metal salts. Sodium monofluorophosphate, sodium fluoride, stannous fluoride and mixtures thereof are preferred. The most preferred fluorine-releasing compound is sodium monofluorophosphate.
- the amount of fluorine-releasing compound should be sufficient to provide 800-1500 ppm fluoride ion.
- Sweeteners well known in the art including natural and artificial sweeteners, may be used in the dentifrice compositions of this invention.
- the sweetener may be selected from a wide range of materials including naturally occurring water-soluble sweeteners, artificial water-soluble sweeteners and modified water-soluble sweeteners derived from naturally occurring water-soluble sweeteners.
- an effective amount of sweetener is utilized to provide the level of sweetness desired in any particular embodiment ofthe dentifrice compositions according to the present invention. This amount will vary with the sweetener selected and the final oral hygiene product.
- flavoring agents include those flavors known to the skilled artisan, such as natural and artificial flavors. Suitable flavoring agents include mints, such as peppermint, citrus flavors such as orange and lemon, artificial vanilla, cinnamon, various fruit flavors, both singly or mixed, and the like. The amount of flavoring agent employed herein is normally a matter of preference subject to such factors as the type of final dentifrice composition, the individual flavor employed, and the strength of flavor desired.
- the coloring agents (colors, colorants) useful in the present invention are used in amounts effective to produce the desired color. These coloring agents include pigments which may be inco ⁇ orated in amounts up to about 6%, by weight ofthe composition. A preferred pigment, titanium dioxide, may be incorporated in amounts up to about 2%, and preferably less than about 1%, by weight ofthe composition. A full recitation of all F D. & C colorants and their corresponding chemical structures may be found in the Kirk-
- Suitable abrasives in the dentifrice include hydrated silica, calcium carbonate, calcium pyrophosphate, dicalcium phosphate dihydrate, or alkali metal meta-phosphates.
- Silica abrasives in the dentifrice composition according to this invention may include among others, ZEODENT® (113), manufactured by J. M. Huber Co ⁇ . and SYLOID® or SYLODENT®, manufactured by W.R. Grace Co. These abrasives may be used in amounts up to about 75.0% w/w ofthe composition, preferably in amounts from about 5.0% w/w to about 40% w/w ofthe composition, and most preferably from about 7.0% w/w to about 30.0% w/w ofthe composition.
- Suitable buffers include citric acid-sodium citrate, acetic acid-sodium acetate, sodium saccharine-acid saccharine, and benzoic acid and benzoate in amounts up to about 1%, and preferably from about 0.05% to about 0.5%, by weight ofthe composition.
- the pH for the preferred embodiment ofthe dentifrice ofthe present invention is from 3.0 to about 5.5.
- Suitable preservatives in this invention include benzoic acid, sodium benzoate, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), ascorbic acid, methyl paraben, propyl paraben, tocopherols and mixtures thereof.
- Preservatives when used are generally present in amounts up to about 1.0% w/w, and preferably from about 0.1% w/w to about 1.0% w/w ofthe dental gel composition.
- Various other materials may be inco ⁇ orated in the dentifrice of this invention. Examples thereof are opacifiers, desensitizing agents, silicones and ammoniated materials such as urea, diammonium phosphate and mixtures thereof. These adjuvants are inco ⁇ orated in the dentifrice in amounts which do not substantially adversely affect the desired properties and characteristics and are suitably selected and used in conventional amounts.
- the dentifrice composition is in the form of toothpaste or a dental gel.
- gel means a solid or semisolid colloid which contains considerable quantities of water. The colloid particles in a gel are linked together in a coherent meshwork which immobilizes the water contained inside the meshwork.
- One skilled in the art would know how to formulate the dentifrice compositions of this invention as a past and a gel.
- an oral antiseptic dentifrice composition according to the present invention is made by first combining water, a source of zinc ion, part ofthe humectant, one or more sweeteners, buffers and preservatives. If fluorine-releasing compounds are used, they are added in this step. The remainder ofthe humectant is separately combined with one or more gums, and then combined with the first mixture. Titanium dioxide and silicas are separately mixed, and combined with the other mixture previously prepared. Finally, colors, essential oils, flavors, and surfactants are added and mixed.
- the pH is adjusted to a pH of about 3.0 to about 5.5 with acidifiers. A vacuum is pulled if necessary for deaeration.
- the pH of a 25.0% w/w aqueous solution ofthe composition is measured using a suitable pH meter (ej ⁇ Orion Research Microprocessor pH/millivolt Meter,
- the apparatus useful in accordance with the present invention comprises mixing apparatus well known in the dental art, and therefore the selection ofthe specific apparatus will be apparent to the artisan.
- the present invention is further illustrated by the following examples which are, however, not included to limit the effective scope ofthe claims All parts and percentages in the examples and throughout the specification and claims are by weight ofthe final composition unless otherwise specified.
- a mouthwash with the ability to prevent the creation of malodors for several hours was prepared by combining the following components in potable water
- Poloxamer 407 2 0 grams
- the above composition was prepared by adding the essential oils (thymol, menthol, methyl salicylate and eucalptol), Poloxamer 407, benzoic acid, and 1 -propanol to ethanol, followed by the addition of 250 ml of potable water
- a dentifrice with zinc chloride and essential oils was formulated.
- Another component in the dentrifrice was hydroxyethylcellulose (Natrosol 250H.) Natrasol 250H in the dentifrice helps reduce the astringency caused by zinc ions.
- the relative antimicrobial activity of several oral compositions of this invention was tested using an ex vivo kinetic kill time assay and a Plaque Kill & Growth kinetics (PKGK) assay.
- kinetic kill time assay saliva suspensions containing natural oral organisms were vigorously mixed with a dentifrice sample in a 3.5: 1 ratio.
- One ml aliquots of the assay mixture were removed and diluted into a neutralizing broth in a 1:9 ratio at 30 and 60 seconds, which periods represent the length of time typically spent in toothbrushing.
- 50 ⁇ l aliquots of diluted suspension were plated on nutrient agar plates, which were incubated anaerobically at 37° C and counted to enumerate surviving microbial colonies.
- Relative antiseptic activity of each dentifrice was determined as a function ofthe number of surviving organisms recovered on agar plates.
- the PKGK assay determined the in vivo antibacterial efficacy of a single dentifrice use in which product was brushed onto one dental quadrant for 15 seconds, then dispersed throughout the mouth for 45 seconds using the tongue and "swishing" in a manner previously described by White et al (J. Dent. Res. 12 A, #1346, 1993; J. Clin. Dent, special issue IV: 59-71, 1995).
- Bactericidal and bacteriostatic effects against plaque microorganisms were assessed by 1 ) quantitative culturing of turbidity-adjusted plaque samples, and 2) growth kinetics analysis (lag time) of the plaque bacterial suspensions incubated in nutrient broth.
- Dentifrice formulations of this invention were prepared using ingredients and quantities as shown in Table 1.
- Formulas 1.1-1.3 of this invention were formulated with increasing levels of zinc chloride plus a constant level of the essential oils thymol, menthol, methyl salicylate and eucalyptol.
- Formulas 2.1-2.3 of this invention were formulated with increasing levels of zinc chloride without essential oils.
- bacteriostatic efficacy of the dentifrice compositions was determined by measuring growth kinetic lag time of the plaque bacterial suspensions incubated in nutrient broth.
- the combination of zinc chloride and essential oils resulted in a significant increase in bacteriostasis compared to the formulas without essential oils
- the enhancement in bacteriostasis by the addition of essential oils became more pronounced in later post-treatment phases, indicating long lasting efficacy
- a clear dose response was observed between zinc chloride levels and bacteriostatic efficacy in the presence of essential oils (formulas 1.1, 1.2 and 1.3).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU27390/97A AU2739097A (en) | 1996-04-26 | 1997-04-24 | Enhanced zinc containing oral composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1680296P | 1996-04-26 | 1996-04-26 | |
US60/016,802 | 1996-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997040812A1 true WO1997040812A1 (en) | 1997-11-06 |
Family
ID=21779051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/006758 WO1997040812A1 (en) | 1996-04-26 | 1997-04-24 | Enhanced zinc containing oral composition |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2739097A (en) |
WO (1) | WO1997040812A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999020238A1 (en) * | 1997-10-23 | 1999-04-29 | Warner-Lambert Company | Metal ion-containing oral products with reduced astringency |
WO1999032075A1 (en) * | 1997-12-22 | 1999-07-01 | Warner-Lambert Company | Compositions for inhibiting gingivitis |
WO2000000166A3 (en) * | 1998-06-29 | 2000-02-10 | Warner Lambert Co | Improved oral compositions for control and prevention of tartar, oral malodor, plaque and gingivitis |
WO2000061092A1 (en) * | 1999-04-08 | 2000-10-19 | Warner-Lambert Company | Zinc containing dentifrice compositions |
WO2000071090A1 (en) * | 1999-05-26 | 2000-11-30 | Dentsply International Inc. | Oral compositions for controlling mouth and breath odors containing a zinc salt |
US6759544B2 (en) | 2001-06-22 | 2004-07-06 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Antimicrobially active acesulfame complexes, process for their preparation and their use |
US6861048B2 (en) | 1999-04-08 | 2005-03-01 | Warner-Lambert Company | Dentifrice compositions having reduced abrasivity |
WO2005058364A3 (en) * | 2003-12-12 | 2006-02-23 | Reckitt Benckiser Healthcare | Preservative system |
US8236348B2 (en) | 2003-02-04 | 2012-08-07 | Bennes, Inc. | Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth |
WO2016036341A1 (en) * | 2014-09-01 | 2016-03-10 | Colgate-Palmolive Company | Zinc-containing compositions with essential oils |
FR3105732A1 (en) * | 2019-12-30 | 2021-07-02 | Ezal Consumer Healthcare | Composition comprising essential oils or components thereof, for preventing or treating oral pathologies |
WO2022099182A1 (en) * | 2020-11-09 | 2022-05-12 | Rucker Capital Advisors | Oral rinse, nasal spray and methods for prevention of covid-19 by lowering viral load of covid-19 |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1435498A (en) * | 1920-01-16 | 1922-11-14 | Ernest D Resnik | Dentifrice |
US1488097A (en) * | 1922-03-09 | 1924-03-25 | Henry N Creger | Dentifrice |
US2527686A (en) * | 1945-12-26 | 1950-10-31 | Max H Sandberg | Mouthwash |
US4170632A (en) * | 1977-11-28 | 1979-10-09 | General Mills, Inc. | Plaque inhibiting compositions and method |
US4325939A (en) * | 1980-09-22 | 1982-04-20 | Richardson-Vicks Inc. | Zinc derivatives and their use in dental compositions |
RO79519A3 (en) * | 1981-09-10 | 1982-08-17 | Intreprinderea De Produse Cosmetice "Nivea",Ro | MEDICAL STAINLESS STEEL |
EP0074082A2 (en) * | 1981-09-03 | 1983-03-16 | Richardson-Vicks, Inc. | Stable oral compositions containing zinc and fluoride compounds |
US4469674A (en) * | 1981-09-03 | 1984-09-04 | Richardson-Vicks Inc. | Stable oral compositions containing zinc and fluoride compounds |
EP0251542A2 (en) * | 1986-06-27 | 1988-01-07 | Lion Corporation | Oral composition |
FR2618670A1 (en) * | 1987-07-28 | 1989-02-03 | Philip Gerard | Medicinal preparation based on essential oils, as well as toothpaste and chewing gum containing it |
WO1993004664A1 (en) * | 1991-09-05 | 1993-03-18 | 7-L Corporation | Mouthrinse and method of preparation |
WO1994026244A1 (en) * | 1993-05-19 | 1994-11-24 | Church & Dwight Co., Inc. | Oral care compositions containing zinc oxide particles and sodium bicarbonate |
US5372803A (en) * | 1993-09-02 | 1994-12-13 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Dental compositions with zinc and bicarbonate salts |
US5405603A (en) * | 1994-01-03 | 1995-04-11 | Mackles; Leonard | Monophasic aqueous compositions containing aromatic lipophiles |
US5407662A (en) * | 1994-01-03 | 1995-04-18 | Mackles; Leonard | Aqueous monophasic compositions containing aromatic lipophiles |
-
1997
- 1997-04-24 AU AU27390/97A patent/AU2739097A/en not_active Abandoned
- 1997-04-24 WO PCT/US1997/006758 patent/WO1997040812A1/en active Application Filing
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1435498A (en) * | 1920-01-16 | 1922-11-14 | Ernest D Resnik | Dentifrice |
US1488097A (en) * | 1922-03-09 | 1924-03-25 | Henry N Creger | Dentifrice |
US2527686A (en) * | 1945-12-26 | 1950-10-31 | Max H Sandberg | Mouthwash |
US4170632A (en) * | 1977-11-28 | 1979-10-09 | General Mills, Inc. | Plaque inhibiting compositions and method |
US4325939A (en) * | 1980-09-22 | 1982-04-20 | Richardson-Vicks Inc. | Zinc derivatives and their use in dental compositions |
EP0074082A2 (en) * | 1981-09-03 | 1983-03-16 | Richardson-Vicks, Inc. | Stable oral compositions containing zinc and fluoride compounds |
US4469674A (en) * | 1981-09-03 | 1984-09-04 | Richardson-Vicks Inc. | Stable oral compositions containing zinc and fluoride compounds |
RO79519A3 (en) * | 1981-09-10 | 1982-08-17 | Intreprinderea De Produse Cosmetice "Nivea",Ro | MEDICAL STAINLESS STEEL |
EP0251542A2 (en) * | 1986-06-27 | 1988-01-07 | Lion Corporation | Oral composition |
FR2618670A1 (en) * | 1987-07-28 | 1989-02-03 | Philip Gerard | Medicinal preparation based on essential oils, as well as toothpaste and chewing gum containing it |
WO1993004664A1 (en) * | 1991-09-05 | 1993-03-18 | 7-L Corporation | Mouthrinse and method of preparation |
WO1994026244A1 (en) * | 1993-05-19 | 1994-11-24 | Church & Dwight Co., Inc. | Oral care compositions containing zinc oxide particles and sodium bicarbonate |
US5372803A (en) * | 1993-09-02 | 1994-12-13 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Dental compositions with zinc and bicarbonate salts |
US5405603A (en) * | 1994-01-03 | 1995-04-11 | Mackles; Leonard | Monophasic aqueous compositions containing aromatic lipophiles |
US5407662A (en) * | 1994-01-03 | 1995-04-18 | Mackles; Leonard | Aqueous monophasic compositions containing aromatic lipophiles |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Week 8309, Derwent World Patents Index; AN 83-21760k, XP002041692 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999020238A1 (en) * | 1997-10-23 | 1999-04-29 | Warner-Lambert Company | Metal ion-containing oral products with reduced astringency |
WO1999032075A1 (en) * | 1997-12-22 | 1999-07-01 | Warner-Lambert Company | Compositions for inhibiting gingivitis |
WO2000000166A3 (en) * | 1998-06-29 | 2000-02-10 | Warner Lambert Co | Improved oral compositions for control and prevention of tartar, oral malodor, plaque and gingivitis |
AU781604B2 (en) * | 1999-04-08 | 2005-06-02 | Warner-Lambert Company Llc | Zinc containing dentifrice compositions |
WO2000061092A1 (en) * | 1999-04-08 | 2000-10-19 | Warner-Lambert Company | Zinc containing dentifrice compositions |
US6221340B1 (en) * | 1999-04-08 | 2001-04-24 | Warner-Lambert Company | Zinc containing dentifrice compositions |
US6861048B2 (en) | 1999-04-08 | 2005-03-01 | Warner-Lambert Company | Dentifrice compositions having reduced abrasivity |
WO2000071090A1 (en) * | 1999-05-26 | 2000-11-30 | Dentsply International Inc. | Oral compositions for controlling mouth and breath odors containing a zinc salt |
US6759544B2 (en) | 2001-06-22 | 2004-07-06 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Antimicrobially active acesulfame complexes, process for their preparation and their use |
US8236348B2 (en) | 2003-02-04 | 2012-08-07 | Bennes, Inc. | Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth |
WO2005058364A3 (en) * | 2003-12-12 | 2006-02-23 | Reckitt Benckiser Healthcare | Preservative system |
WO2016036341A1 (en) * | 2014-09-01 | 2016-03-10 | Colgate-Palmolive Company | Zinc-containing compositions with essential oils |
AU2014405603B2 (en) * | 2014-09-01 | 2018-03-29 | Colgate-Palmolive Company | Zinc-containing compositions with essential oils |
FR3105732A1 (en) * | 2019-12-30 | 2021-07-02 | Ezal Consumer Healthcare | Composition comprising essential oils or components thereof, for preventing or treating oral pathologies |
WO2022099182A1 (en) * | 2020-11-09 | 2022-05-12 | Rucker Capital Advisors | Oral rinse, nasal spray and methods for prevention of covid-19 by lowering viral load of covid-19 |
Also Published As
Publication number | Publication date |
---|---|
AU2739097A (en) | 1997-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU698788B2 (en) | Antiseptic dentifrice | |
US5891422A (en) | Antimicrobial composition containing a C3 -C6 alcohol | |
AU2005203789A1 (en) | Zinc containing dentifrice compositions | |
EP3082724A1 (en) | Oral care composition | |
AU730963B2 (en) | Anticalculus dentifrice containing highly soluble pyrophosphate | |
US9408870B2 (en) | Oral care composition | |
AU714067B2 (en) | Antimicrobial compositions containing a C3-C6 alcohol | |
WO1997040812A1 (en) | Enhanced zinc containing oral composition | |
DE69114708T2 (en) | AGENT AGAINST TARTAR AND COVERAGE CONTAINING AZACYCLOALKANE DIPHOSPHONIC ACID DERIVATIVES. | |
US20040258632A1 (en) | Stable aqueous antiplaque oral compositions | |
US20040258631A1 (en) | Oral care compositions exhibiting antiplaque and breath freshening properties | |
US20040067203A1 (en) | Multi-benefit oral hygiene product | |
US20040241109A1 (en) | Multi-benefit oral hygiene product | |
EP2621458B1 (en) | Antimicrobial dental care preparation | |
KR100759518B1 (en) | Oral composition for bad breath | |
WO2000078276A1 (en) | Multi-benefit oral hygiene product | |
JPH01246214A (en) | Composition for oral cavity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AU BA BB BG BR CA CN CZ EE GE GH HU IL IS JP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK TR TT UA UZ VN YU AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97539000 Format of ref document f/p: F |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
122 | Ep: pct application non-entry in european phase |